Abstract:Background: Mortality, suicide, self-harm, and substance use are elevated among people who are incarcerated. There is a wide range of heterogeneous interventions aimed at reducing these harms in this population. Previous reviews have focused on specific interventions or limited their findings to drug use and recidivism and have not explored interventions delivered after release from prison. Our aim is to examine the effect of interventions delivered to people who use drugs during incarceration or after release from incarceration, on a wide range of outcomes. Methods: In this systematic review and meta-analysis, we searched Embase, MEDLINE, and PsycINFO databases up until Sept 12, 2023 for studies published from Jan 1, 1980 onwards. All studies evaluating the effectiveness of any intervention on drug use, recidivism outcomes, sexual or injecting risk behaviours, or mortality among people who use psychoactive drugs and who were currently or recently incarcerated were included. Studies without a comparator or measuring only alcohol use were excluded. Data extracted from each study included demographic characteristics, interventions, and comparisons. Pooled odds ratios and risk ratios were calculated using random-effects meta-analyses. Findings: We identified 126 eligible studies (47 randomised controlled trials and 79 observational studies) encompassing 18 interventions; receiving opioid-agonist treatment (OAT) in prison reduced the risk of death in prison (one study; hazard ratio 0·25; 95% CI 0·13-0·48), whereas receiving OAT in the first 4 weeks following release reduced risk of death in the community (two studies; relative risk 0·24; 95% CI 0·15-0·37). Therapeutic community interventions reduced re-arrest at 6-12 months (six studies; odds ratio [OR] 0·72; 95% CI 0·55-0·95) and reincarceration at 24 months (two studies; OR 0·66; 95% CI 0·48-0·96). There was scarce evidence that OAT and syringe service provision are effective in reducing injecting risk behaviours and needle and syringe sharing. Interpretation: There are effective interventions to reduce mortality and recidivism for people who use drugs who have been incarcerated. Nonetheless, there are also substantial gaps in the research examining the effect of interventions on risk behaviours and mortality during incarceration and a need for randomised designs examining outcomes for people who use drugs after release. Funding: Australian National Health and Medical Research Council.

A Prospective Study of Injection Drug Use and Jail Readmission in Two Western North Carolina Counties

Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women

Perceptions of neighborhood social environment and drug dependence among incarcerated women and men: a cross-sectional analysis

Preventing Relapse in Incarcerated Drug Users in Yunnan Province, China.

Protective Factors Associated With Lower Likelihood of Injection Drug Use and Experiencing Overdose Among Incarcerated Women

Adverse Childhood Experiences and Co-Occurring Disorders: Is There a Relationship Among ACEs, Mental Health Issues, and Substance Use Among Inmates?

Overdose Experiences Among a Sample of Women in Jail with Opioid Use Disorder

Immigrant background, incarceration history and recidivism among adults assessed for illicit substance use severity: Findings from a Swedish registry study

Jail Characteristics and Availability of Opioid Treatment Services: Results from a Nationally Representative Survey

Access to HIV care in jails: Perspectives from people living with HIV in North Carolina

Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital

Drug Use-Related Discrimination in Healthcare Settings and Subsequent Emergency Department Utilization in a Prospective Cohort Study of People With a History of Injection Drug Use

Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis

Community relationship quality and reincarceration following rural drug-using women's reentry from jail

The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal

Informing an Intervention to Improve Access to Community Pharmacist-Provided Injectable Naltrexone for Formerly Incarcerated Individuals in Wisconsin

Increased Hospital and Emergency Department Utilization by Individuals with Recent Criminal Justice Involvement: Results of a National Survey

Jail-based substance user treatment: an analysis of retention

Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration

Substance Use Disorders and HIV/AIDS Risk Behaviors in Youth After Juvenile Detention: A 16-Year Longitudinal Study

Community-based Services for Hospitalized Patients with Serious Injection-Related Infections in Alabama: A Brief Report